The Workplace-Based Hypertension Management Program

N/ANot Yet RecruitingNCT07265193

Guangxi Medical University512 enrolled

Overview

This study aims to evaluate the effectiveness of a workplace-based, multicomponent hypertension management program for newly diagnosed patients. Investigators will recruit 512 participants (256 pairs) from the Kailuan Study in Tangshan, China. Participants will be randomly assigned to receive a Workplace-based Multicomponent Hypertension Management Program or Standard Workplace Health Management. The primary objective is to assess improvements in blood pressure control and hypertension-related health behaviors.

Hypertension is a major public health issue worldwide, and workplace settings represent a critical intervention opportunity for middle-aged populations. Nudge theory provides a cost-effective and behaviorally informed approach to promote sustainable health behaviors. This randomized controlled trial (RCT) will explore mechanisms of health behavior promotion, evaluate the effectiveness of a nudge-based workplace health management strategy, and contribute to evidence-based hypertension prevention and control in China.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

PREVENTION

Masking

QUADRUPLE

Enrollment

512

Conditions

Hypertension

Interventions

Workplace-based Multicomponent Hypertension Management ProgramBEHAVIORAL

Multicomponent strategies, including default scheduling of BP monitoring and counseling sessions, personalized reminders via workplace digital systems, social comparison feedback using anonymized peer data, small incentives and commitment devices.

Routine workplace health education and management according to current guidelines.OTHER

Routine workplace health education and management according to current guidelines, including routine health education, standard hypertension counseling, and usual workplace health services.

Eligibility

Sex: ALLMin age: 18 YearsMax age: 60 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * Adults aged 18-60 years * Newly diagnosed hypertension (per 2024 Chinese hypertension guideline criteria) * Employed in Kailuan Group workplace settings * Able to provide informed consent Exclusion Criteria: * Severe cardiovascular or renal disease at baseline * Psychiatric disorders affecting compliance * Pregnant or lactating women * Participation in other intervention trials

Locations (1)

Yan-Feng Zhou

Nanning, Guangxi, China

Outcomes

Primary Outcomes

Change in systolic and diastolic blood pressure

Change in systolic and diastolic blood pressure from baseline to 12 months

Time frame: up to 12 months

Secondary Outcomes

Changes in hypertension-related health behaviors

Changes in hypertension-related health behaviors (dietary intake, physical activity, medication adherence) at 12 months

Time frame: up to 12 months

Change in body mass index (BMI)

Change in body mass index (BMI) at 12 months

Time frame: up to 12 months

Work productivity and quality of life scores

Work productivity and quality of life scores (e.g., the European Quality of Life-5 Dimensions) at 12 months

Time frame: up to 12 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.